Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited

Pharmaceutical Manufacturing

Bangalore, Karnataka 84,206 followers

Innovation Accelerated.

About us

Aurigene Pharmaceutical Services is leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery and development our mission is to relentlessly work for the success of our clients and to build long term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market. By providing access to our resources, knowledge and experience, we create success for our clients and ultimately patients. We offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development and manufacturing for clinical phase I-III programs, regulatory submission batches and commercial manufacturing. A differentiating factor is the integrated API and formulations service that spans from key starting material, advanced intermediates, APIs to finished products such as oral solids, sterile products, nasal solutions etc. Our development services in India are complemented by cGMP commercial manufacturing facilities in the UK, Mexico, USA and India. For more details, you can write to us at [email protected]

Website
http://www.aurigeneservices.com/
Industry
Pharmaceutical Manufacturing
Company size
501-1,000 employees
Headquarters
Bangalore, Karnataka
Type
Public Company
Specialties
HPAPIs, Activated mPEGS, Steroids, Formulation Services (pre-formulation, DS + DP), Drug Development, biologics, Peptide, Oligonucleotides, Targeted Protein Degradation, DNA Encoded Libraries, Drug discovery, AI-assisted drug discovery, In vitro biology, DMPK, In vivo pharmacology, Microbiology, Toxicology, Custom library synthesis, Early phase development, Flow chemistry, mAbs, Bispecifics, Recombinant proteins, monoclonal antibodies, T cell redirectors, immuno-fusion molecules, Cytokines, cell line development, CGPM manufacturing, dosage formulations, solid orals, liquid orals, topical dosage , injectible formulations, ophthalmic dosage, otic dosage, nasal dosage, crystallization, polymorphism, CDMO services, CRO services, non-GMP pilot facility, and Analytical method development

Locations

  • Primary

    39-40, KIADB Industrial Area, Electronic City Phase - II, Hosur Road

    Bangalore, Karnataka 560100, IN

    Get directions

Employees at Aurigene Pharmaceutical Services Limited

Updates

  • 🌟 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲 𝗣𝗵𝗮𝗿𝗺𝗮! 🌟 The countdown has begun for Aurigene Fest 2024—a celebration of innovation, collaboration, and excellence! 🎉 We’re gearing up for an unforgettable event, packed with insightful sessions, amazing activities, opportunities to connect with our vibrant community and reflecting our commitment to excellence in the pharma industry, A big thank you to everyone who made this possible! Let’s make this event a memorable one. ✨ 𝗦𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱 𝗳𝗼𝗿 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 as we unveil the theme, schedule, and all the exciting details in the coming weeks! Let’s make this fest a truly memorable one. 🚀💙   #AurigenePharmaFest2024 #Innovation #Teamwork #Celebration #PharmaExcellence

  • 𝗛𝗮𝗽𝗽𝘆 𝗧𝗵𝗮𝗻𝗸𝘀𝗴𝗶𝘃𝗶𝗻𝗴 𝗳𝗿𝗼𝗺 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲! 🎃🍁 This Thanksgiving, we want to pause and express our heartfelt gratitude to everyone who makes our journey meaningful:   🤝💊𝗢𝘂𝗿 𝗖𝘂𝘀𝘁𝗼𝗺𝗲𝗿𝘀: Thank you for trusting us. Your dedication to advancing healthcare inspires us to strive for excellence every day. Together, we are making significant strides in improving patient outcomes and pushing the boundaries of pharmaceutical innovation. 🔬🧬𝗢𝘂𝗿 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀: Your collaboration fuels innovation and helps us reach new milestones. Together, we’re transforming lives and building a healthier tomorrow. 👩⚕️👨🔬 𝗢𝘂𝗿 𝗘𝗺𝗽𝗹𝗼𝘆𝗲𝗲𝘀: Your passion, dedication, and relentless pursuit of progress are the backbone of our success. You are the true heroes behind every breakthrough we achieve.   As we reflect on this year, we’re reminded of the power of working together to make a difference. From all of us at Aurigene, we wish you a Thanksgiving filled with joy, warmth, and moments of gratitude.🌍✨ Here’s to a season of health, happiness, and continued growth. Thank you for being an essential part of our journey! 🧡   #Thanksgiving #Gratitude #PharmaCommunity #HealthyFuture #TogetherWeThrive

    • No alternative text description for this image
  • 📢 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗮 𝗥𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗹𝗲 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵! 🌟🚀 We are excited to announce the publication of our latest research: "𝙌𝙪𝙞𝙣𝙤𝙡𝙞𝙣𝙚 𝙃𝙮𝙗𝙧𝙞𝙙 𝘿𝙚𝙧𝙞𝙫𝙖𝙩𝙞𝙫𝙚𝙨 𝙖𝙨 𝙀𝙛𝙛𝙚𝙘𝙩𝙞𝙫𝙚 𝙎𝙩𝙧𝙪𝙘𝙩𝙪𝙧𝙖𝙡 𝙈𝙤𝙩𝙞𝙛𝙨 𝙞𝙣 𝙩𝙝𝙚 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙤𝙛 𝙏𝙪𝙗𝙚𝙧𝙘𝙪𝙡𝙤𝙨𝙞𝙨: 𝙀𝙢𝙥𝙝𝙖𝙨𝙞𝙨 𝙤𝙣 𝙎𝙩𝙧𝙪𝙘𝙩𝙪𝙧𝙚-𝘼𝙘𝙩𝙞𝙫𝙞𝙩𝙮 𝙍𝙚𝙡𝙖𝙩𝙞𝙤𝙣𝙨𝙝𝙞𝙥𝙨" 🎉   Tuberculosis (TB) remains one of the deadliest infectious diseases, with multidrug-resistant (MDR-TB), extensively drug-resistant (XDR-TB), and even completely drug-resistant (TDR-TB) strains posing significant global health challenges. The pressing need for novel therapeutic agents inspired us to delve into the potential of 𝗾𝘂𝗶𝗻𝗼𝗹𝗶𝗻𝗲 𝗵𝘆𝗯𝗿𝗶𝗱 𝗱𝗲𝗿𝗶𝘃𝗮𝘁𝗶𝘃𝗲𝘀.   🔍 𝗪𝗵𝗮𝘁 𝗺𝗮𝗸𝗲𝘀 𝗾𝘂𝗶𝗻𝗼𝗹𝗶𝗻𝗲 𝗲𝘅𝗰𝗶𝘁𝗶𝗻𝗴?      ✅ 𝗟𝗼𝘄 𝘁𝗼𝘅𝗶𝗰𝗶𝘁𝘆 and 𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗲 pharmacological properties    ✅ Potential to overcome resistance mechanisms    ✅ Promise in designing next-generation anti-TB agents   We are honored to contribute to the advancement of medicinal chemistry and public health through this work. Our heartfelt gratitude goes out to the entire research team—📖 Venkatraman Hegde, Raveendra Bhat, Srinivasa Budagumpi, Dr.Vinayak Adimule, and Dr. Ranganath Keri —whose dedication and expertise made this achievement possible.   💡 Interested in discussing or collaborating on quinoline research or sustainable healthcare solutions? Let’s connect! 🔗 Learn more: https://lnkd.in/gXST6Q6A 📧 Contact us: [email protected] Let’s pave the way for a healthier tomorrow! 🌍✨   #TuberculosisTreatment #MedicinalChemistry #QuinolineDerivatives #GlobalHealth #ScientificInnovation

    • No alternative text description for this image
  • 🌟 𝗠𝗲𝗲𝘁 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲’𝘀 𝗘𝘅𝗽𝗲𝗿𝘁𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗘𝘃𝗲𝗻𝘁 𝟮𝟬𝟮𝟰! 🌟 Aurigene’s thought leaders, 𝗗𝗿. Roger Lias (Global Commercial Head - NBE) and Jenny Yip (Sr. Director, Business Development - Biologics, North America), will be at the forefront of innovation at this year's 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗘𝘃𝗲𝗻𝘁. 🚀   📅 𝗘𝘃𝗲𝗻𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝘀 ✔️𝗗𝗮𝘁𝗲: December 15-18, 2024 ✔️𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Marriott Marquis San Diego ✔️𝗕𝗼𝗼𝘁𝗵: #618   This is your chance to engage directly with pioneers in biologics. Whether it’s advancing antibody engineering or exploring groundbreaking biologics solutions, our team is ready to connect and collaborate.   🎯 𝗦𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 – write to us at [email protected].  Let’s explore the future of antibody engineering, together. See you in San Diego! 🌐   #Aurigene #AntibodyEngineering #Therapeutics #Biologics #Pharma #Biotech #Innovation #DrugDevelopment #Conference #SanDiego

    • No alternative text description for this image
  • 🔬 𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗤𝘂𝗮𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗟𝗖-𝗠𝗦/𝗠𝗦 𝗳𝗼𝗿 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 🔬 Aurigene recently tackled a challenging LC-MS/MS quantification project for a highly polar, rarely encountered peptide in a biotech discovery process. Our team’s expertise turned multiple analytical hurdles into milestones:   ⚠️ 𝗞𝗲𝘆 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀: 🔺Low Sensitivity: Fragment ions generated were <200 amu, challenging detection. 🔺Matrix Effect: Interference from other matrix components affected accuracy. 🔺Low Retention: Limited retention of this peptide on traditional LC columns.   💡 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲'𝘀 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻: 🧬Optimization: We explored different charge states and optimized the MS/MS parameters, with Q3 yielding the best response. 🧬Matrix Effect Reduction: Tested various SPE cartridges and found HLB cartridges, preconditioned to effectively reduce matrix interference. 🧬Retention Improvement: Modified LC conditions and tried several columns, successfully achieving optimal retention.   Aurigene’s innovative approach ensured precise, reliable quantification, driving our client’s discovery pipeline forward. 📩 𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲?  Connect with us today to discuss how our DMPK capabilities can support your next breakthrough. 🔗 Learn more: https://lnkd.in/drsBNwu3 🔗 Contact us: [email protected]   #Biotech #PeptideQuantification #LCMSMS #AnalyticalSolutions #InnovationInScience #Aurigene

  • 🚀 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗣𝗥𝗢𝗧𝗔𝗖𝘀 𝘄𝗶𝘁𝗵 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲’𝘀 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 🚀  With a decade of experience in integrated drug discovery, from the precision synthesis of PROTACs to in-depth molecular profiling. Our comprehensive capabilities, including Computer-Aided Drug Design (CADD) and expertise in molecular glues, empower us to deliver impactful therapeutic solutions.    💡 𝗪𝗵𝘆 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝘄𝗶𝘁𝗵 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲?  🌟𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗧𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀: Advanced synthetic methodologies for high-purity PROTAC synthesis.  🌟𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗣𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴: Comprehensive analysis for robust efficacy and safety data.  🌟𝗘𝗻𝗱-𝘁𝗼-𝗘𝗻𝗱 𝗦𝘂𝗽𝗽𝗼𝗿𝘁: Seamless integration across the discovery, development, and optimization phases.    🌱 Join us on this journey and take your PROTACs to the next phase  Explore how we are advancing the boundaries of targeted therapy through PROTAC innovation. Together, we’re shaping a future where precision medicine leads the way in cancer treatment.  🔗 Learn more: https://lnkd.in/gQcjmwvU 📧 Reach out to us: [email protected] #AurigenePharmaceuticals #PROTACs #DrugDiscovery #Innovation #TargetedTherapies #HealthcareAdvancement

    • No alternative text description for this image
  • 🌟 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 & 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 🌟 We are elated to announce a groundbreaking partnership between 𝗔𝘂𝗿𝗶𝗴𝗲𝗻𝗲 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗟𝘁𝗱. and CSIR-INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY! 🔬🎉   This collaboration marks a pivotal moment in shaping the next generation of industry leaders. Through a meticulously designed 𝟯-𝗺𝗼𝗻𝘁𝗵 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗰𝗹𝗮𝘀𝘀𝗿𝗼𝗼𝗺 𝗮𝗻𝗱 𝗹𝗮𝗯 𝘁𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗽𝗿𝗼𝗴𝗿𝗮𝗺, we aim to: ✅ Equip fresh talent with 𝘀𝘁𝗮𝘁𝗲-𝗼𝗳-𝘁𝗵𝗲-𝗮𝗿𝘁 knowledge  ✅ Provide 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 to navigate the dynamic landscape of the chemical and pharmaceutical sectors  ✅ Bridge the gap between 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗰 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 and 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗱𝗲𝗺𝗮𝗻𝗱𝘀   This initiative underscores our unwavering commitment to 𝗻𝘂𝗿𝘁𝘂𝗿𝗶𝗻𝗴 𝘁𝗮𝗹𝗲𝗻𝘁, 𝗳𝗼𝘀𝘁𝗲𝗿𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗮 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗽𝗶𝗽𝗲𝗹𝗶𝗻𝗲 𝗼𝗳 𝘀𝗸𝗶𝗹𝗹𝗲𝗱 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 ready to thrive in their careers. A heartfelt thank you to everyone who believed in this vision and worked tirelessly to bring it to life. Together, we are not just preparing for the future — we are shaping it. 🌍🚀 Let’s continue to drive excellence, one bold step at a time! #Innovation #Upskilling #TalentDevelopment #ScienceAndTechnology #Aurigene #IICT Ashutosh Kotwal Anuj Singh Sangamesh Badiger gayathri sigamani Shahadat Ahmed Priyaranjan Pattanaik Naresh Dantala Shailaja Donempudi Dr. Sridhar Dr. Debasish Swain @Dr. Suresh Surisetti Anil Kumar P

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Aurigene Pharmaceutical Services Limited reposted this

    View profile for Tushar Zade, graphic

    CDO & CIO | IIMA | 40 under 40 | Most Prominent Digital Transformation Leader Awardee | Indian Achievers' Awardee | The Global Choice Award - CDO of the year | Trendsetter CIO Awardee | Innovative CIO Awardee

    View organization page for ET Pharma, graphic

    7,143 followers

    We are excited to introduce Tushar Zade, CIO & CDO of Aurigene Pharmaceutical Services Limited, as one of our key speakers! Tushar brings a wealth of experience in leveraging digital technologies and data to accelerate pharmaceutical innovation. Hear his insights on the future of digital transformation in the pharma sector. Don’t miss this chance to learn from a leader at the forefront of pharma-tech innovation. Register Now: https://bit.ly/3ZQRJUQ #PharmaTech #InnovationInPharma #HealthcareTech #PharmaInnovation #PharmaTech2024

    • No alternative text description for this image

Similar pages

Browse jobs